Check Before You Invest : Indrayani Biotech Ltd

BSE: 526445 NSE: ISIN: INE007C01021

| Sector: Diversified | Industry: Diversified

Snapshot

Q.1 Which industry/sub-sector does Indrayani Biotech Ltd belong to?

Indrayani Biotech Ltd belongs to the Diversified sector, operating specifically within the Diversified segment.

Q.2 Is Indrayani Biotech Ltd a good quality company?

Indrayani Biotech Ltd is a quality company, based on a 6-year financial track record.

Q.3 Is Indrayani Biotech Ltd undervalued or overvalued?

Indrayani Biotech Ltd appears Somewhat overvalued, as its key valuation ratios are above with their past averages.

Q.4 Is Indrayani Biotech Ltd a good buy now?

Indrayani Biotech Ltd is not a good buy now, based on weak price trend analysis suggesting prices may fall. However, you need to check its quality and valuation before making a decision

Performance Analysis

Q.1 Revenue growth of Indrayani Biotech Ltd?

Indrayani Biotech Ltd revenue growth is -39.4% for FY-2025, which is below its 5-year CAGR of 137.48%, indicating slower growth.

Q.2 Return on capital employed (ROCE) of Indrayani Biotech Ltd?

Indrayani Biotech Ltd Return on capital employed is 6.99% for FY-2025, which is below its 5-year historical median of 7.99%. The current ROCE is below its estimated weighted average cost of capital (WACC) of 14%, indicating value preservation.

Q.3 Return on Asset of Indrayani Biotech Ltd?

Indrayani Biotech Ltd Return on Asset is 1.13%, which is below its 5-year historical median of 1.29%, indicating deteriorated asset utilization efficiency.

Q.4 Return on Equity (ROE) of Indrayani Biotech Ltd?

Indrayani Biotech Ltd Return on equity is 2.83% for FY-2025, which is below its 5-year historical median of 3.21%, indicating the business is making worse use of its shareholders capital.

Q.5 Cash conversion cycle of Indrayani Biotech Ltd?

Indrayani Biotech Ltd Cash conversion cycle is 114 days, above its 5-year historical median of 56 days, indicating deteriorated working capital management. However, you need to compare this with its peers in the industry.

	Current Level	5-year Historic Median
Asset Turnover	0.29	0.99
ROE	2.83	3.21
ROCE	6.99	7.99
Cash Conversion Cycle	114 days	56 days

Q.6 Gross Profit margin of Indrayani Biotech Ltd?

Indrayani Biotech Ltd Gross profit margin which is the profit after deduction of direct costs, is 4.4% for FY-2025, which is below its 5-year median of 7.2%, indicating decreasing margins.

Q.7 Operating Profit Margin of Indrayani Biotech Ltd?

Indrayani Biotech Ltd Operating Profit Margin which is the profit after deduction of all operating costs, is 14.71% for FY-2025, which is above its 5-year median of 10.76% indicating increasing margins.

Q.8 Net Profit Margin of Indrayani Biotech Ltd?

Indrayani Biotech Ltd Net Profit Margin is 3.83% for FY-2025, is in line with with its 5-year median of 3.83%, indicating stable margins.

	Current Level	5-year Historic Median
Gross Profit Margin	4.4	7.2
Operating Profit Margin	14.71	10.76
Net Profit Margin	3.83	3.83

Q.9 Debt to Equity ratio of Indrayani Biotech Ltd?

Indrayani Biotech Ltd Debt-to-Equity ratio is 1.19, which is above with the industry average of 0.27, indicating higher debt levels in the industry.

Q.10 Debt to cash flow from operations of Indrayani Biotech Ltd?

Indrayani Biotech Ltd Debt to cash flow from operations is 3.55, which is at a unhealthy level.

Ownership & governance

Q.1 Promoter shareholding and pledge status of Indrayani Biotech Ltd?

Promoters hold 33.26% of the Indrayani Biotech Ltd, with 24.56% of their stake pledged, indicating high pledge risk.

Peer comparison (industry-wise, mcap)

Q.1 Revenue growth of Indrayani Biotech Ltd vs industry peers?

Indrayani Biotech Ltd revenue CAGR is 137.48%, compared to the industry median CAGR of 9.61%, indicating faster growth and gaining its market share.

Profit Metrics

	Current Level	5-year Industry Median
Revenue Growth	-39.4	9.6
Gross Profit Growth	-62.6	20.3
Operating Profit Growth	-4.3	8.4
Net Profit Growth	-0.7	35

Operating Efficiency

	Current Level	5-year Industry Median
Asset Turnover	0.29	0.83
ROE	2.83	5.7
ROCE	6.99	8.07
Cash Conversion Cycle (days)	114.43	59

Valuation & price assessment

Q.1 Stock return of Indrayani Biotech Ltd over the last decade?

Over the last 9 year(s), the stock has delivered a CAGR of 5.7% based on the current price.

Q.2 What return has the stock given over the last decade?

	9Y	5Y	3Y	1Y
Share Price CAGR	5.7%	13.8%	-46.1%	-34%

Q.3 Valuation ratios of Indrayani Biotech Ltd vs historical?

The current P/E is lower that its historical median.

Q.4 How do the current valuation ratios compare with 5-year historical median and industry numbers?

Valuation Ratios	Current	5-year Historic Median	5-year Industry Median
Price to Earnings	50.21	59.37	16.35
Price to Book	0.86	4.03	1.78
Price to Sales	3.31	2.68	1.43
EV to EBITDA	21.72	25.77	9.56

Check more companies

1. DCM Shriram

2. Hindustan Foods

3. Balmer Lawrie & Co

4. Kothari Indl. Corp

5. TTK Healthcare

6. Empire Inds

7. Gillanders Arbuthnot

8. Aspinwall & Co

9. TCI Industries

10. Indrayani Biotech

Check trending companies

1. Indraprastha Gas Ltd.

2. Oracle Financial Services Software Ltd.

3. Dr. Lal Pathlabs Ltd.

4. Vedant Fashions Ltd.

5. Alkyl Amines Chemicals Ltd.